CLOs on the Move

Surgery Partners

www.surgerypartners.com

 
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Spencer Clark
SVP and General Counsel Profile
Roxanne Womack
SVP, Chief Compliance Officer Profile
Spencer Clark
VP and Senior Legal Counsel Profile
Kelly Whelan
VP and Senior Legal Counsel, American and Eastern Groups Profile

Similar Companies

Cook Children's Medical Center - Cook Children's Community Clinics

Cook Children's Medical Center - Cook Children's Community Clinics is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gift of Hope

Gift of Hope Organ & Tissue Donor Network is a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana. As one of 58 OPOs that make up the nation’s donation system, we work with 180 hospitals and serve 12 million people in our donation service area. Since 1986, we have saved the lives of more than 23,000 organ transplant recipients and improved the lives of hundreds of thousands of tissue transplant recipients through our efforts.

St. John's

St. Johns Lutheran Community is a senior living community in Albert Lea, MN that provides short term care, skilled nursing care, independent living, assisted living, and memory care homes.

Nkarta Therapeutics

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.